Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Journal of the American Society of Nephrology : JASN
|
October 7, 2004
Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of risk
Denis Cournoyer, Edwin B Toffelmire, George A Wells, et al.
Leukemia & Lymphoma
|
December 24, 2011
Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy
Adisak Tantiworawit, Maryse M Power, Michael J Barnett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 14, 2015
Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors
Anish P Nair, Michael J Barnett, Raewyn C Broady, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 21, 2006
Early stem cell transplantation for refractory acute leukemia after salvage therapy with high-dose etoposide and cyclophosphamide
Asha Johny, Kevin W Song, Stephen H Nantel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2005
High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation
Donna L Forrest, Donna E Hogge, Thomas J Nevill, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 17, 2009
Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantation
Matthew P Wright, John D Shepherd, Michael J Barnett, et al.
Cancer Genetics and Cytogenetics
|
September 13, 2006
Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors
Yulia Lin, Hélène Bruyère, Douglas E Horsman, et al.
Leukemia & Lymphoma
|
July 16, 2005
Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remission
Kevin W Song, Peter N Mollee, Donna E Hogge, et al.
British Journal of Haematology
|
October 4, 2005
Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma
Richard T Doocey, Cynthia L Toze, Joseph M Connors, et al.
British Journal of Haematology
|
May 18, 2006
Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma
Kevin W Song, Michael J Barnett, Randy D Gascoyne, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Journal of the American Society of Nephrology : JASN
|
October 7, 2004
Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of risk
Denis Cournoyer, Edwin B Toffelmire, George A Wells, et al.
Leukemia & Lymphoma
|
December 24, 2011
Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy
Adisak Tantiworawit, Maryse M Power, Michael J Barnett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 14, 2015
Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors
Anish P Nair, Michael J Barnett, Raewyn C Broady, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 21, 2006
Early stem cell transplantation for refractory acute leukemia after salvage therapy with high-dose etoposide and cyclophosphamide
Asha Johny, Kevin W Song, Stephen H Nantel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2005
High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation
Donna L Forrest, Donna E Hogge, Thomas J Nevill, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 17, 2009
Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantation
Matthew P Wright, John D Shepherd, Michael J Barnett, et al.
Cancer Genetics and Cytogenetics
|
September 13, 2006
Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors
Yulia Lin, Hélène Bruyère, Douglas E Horsman, et al.
Leukemia & Lymphoma
|
July 16, 2005
Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remission
Kevin W Song, Peter N Mollee, Donna E Hogge, et al.
British Journal of Haematology
|
October 4, 2005
Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma
Richard T Doocey, Cynthia L Toze, Joseph M Connors, et al.
British Journal of Haematology
|
May 18, 2006
Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma
Kevin W Song, Michael J Barnett, Randy D Gascoyne, et al.
Page
of 5